ILMN
ILLUMINA, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$262.66
+0.05%Forward multiples
Based on analyst estimates
- P/E forward
- 44.38x
- P/E 2026E
- 49.14x
- P/E 2027E
- 43.17x
- P/E 2028E
- 37.70x
- P/S forward
- 8.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- 48.55x
- PEG TTM
- 5.18x
- Price / book
- 13.98x
- Price / sales
- 8.83x
- Price / cash flow
- 36.22x
Enterprise value
- Enterprise value
- $41.0B
- EV / sales
- 9.13x
- EV / EBITDA
- 30.10x
- EV / EBIT
- 43.55x
- Market cap
- $39.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026